Astragalus Polysaccharide Modulates the Gut Microbiota and Metabolites of Patients with Type 2 Diabetes in an In Vitro Fermentation Model
Nutrients · 2024
DOI: 10.3390/nu16111698 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Xin Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Diabetes Mellitus, Type 2, Fermentation, Polysaccharides. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jinan Innovation Team Project, National Natural Science Foundation of China, National Key R&D Program of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
This study investigated the effect of astragalus polysaccharide (APS, an ingredient with hypoglycemic function in a traditional Chinese herbal medicine) on gut microbiota and metabolites of type 2 diabetes mellitus (T2DM) patients using a simulated fermentation model in vitro. The main components of APS were isolated, purified, and structure characterized. APS fermentation was found to increase the abundance of Lactobacillus and Bifidobacterium and decrease the Escherichia-Shigella level in the fecal microbiota of T2DM patients. Apart from increasing propionic acid, APS also caused an increase in all-trans-retinoic acid and thiamine (both have antioxidant properties), with their enrichment in the KEGG pathway associated with thiamine metabolism, etc. Notably, APS could also enhance fecal antioxidant properties. Correlation analysis confirmed a significant positive correlation of Lactobacillus with thiamine and DPPH-clearance rate, suggesting the antioxidant activity of APS was related to its ability to enrich some specific bacteria and upregulate their metabolites.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China.
- Key Laboratory of Industrial Fermentation Microbiology, Ministry of Education and Tianjin, Tianjin 300457, China.
- Shandong Academy of Pharmaceutical Sciences, Key Laboratory of Biopharmaceuticals, Engineering Laboratory of Polysaccharide Drugs, National-Local Joint Engineering Laboratory of Polysaccharide Drugs, Postdoctoral Scient…
- The Center of Gerontology and Geriatrics, National Clinical Research Center of Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China.
- Institute of Food Science, Zhejiang Academy of Agricultural Sciences, Hangzhou 310021, China.
ORCID-Profile: Nan Wang
Förderung
- Jinan Innovation Team Project
- National Natural Science Foundation of China
- National Key R&D Program of China
- National Key R&D Program of China
Zitieren
APA
Zhang, X., Jia, L., Ma, Q., Zhang, X., Chen, M., Liu, F., Zhang, T., Jia, W., Zhu, L., Qi, W., & Wang, N. (2024). Astragalus Polysaccharide Modulates the Gut Microbiota and Metabolites of Patients with Type 2 Diabetes in an In Vitro Fermentation Model. Nutrients. https://doi.org/10.3390/nu16111698
Vancouver
Zhang X, Jia L, Ma Q, Zhang X, Chen M, Liu F, et al. Astragalus Polysaccharide Modulates the Gut Microbiota and Metabolites of Patients with Type 2 Diabetes in an In Vitro Fermentation Model. Nutrients. 2024. doi:10.3390/nu16111698
BibTeX
@article{Zhang2024,
author = {Zhang, Xin and Jia, Lina and Ma, Qian and Zhang, Xiaoyuan and Chen, Mian and Liu, Fei and Zhang, Tongcun and Jia, Weiguo and Zhu, Liying and Qi, Wei and Wang, Nan},
title = {Astragalus Polysaccharide Modulates the Gut Microbiota and Metabolites of Patients with Type 2 Diabetes in an In Vitro Fermentation Model},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16111698}
}
EUVIMED